Pages that link to "Q34409942"

The following pages link to Azathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration (Q34409942):

Displaying 38 items.

• Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease (Q24197676) (← links)
• Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease (Q24234935) (← links)
• Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease (Q24240676) (← links)
• Utilisation of erythrocyte 6-thioguanine metabolite levels to optimise azathioprine therapy in patients with inflammatory bowel disease (Q28362619) (← links)
• Model-based contextualization of in vitro toxicity data quantitatively predicts in vivo drug response in patients. (Q30838395) (← links)
• Pharmacogenomics and metabolite measurement for 6-mercaptopurine therapy in inflammatory bowel disease (Q33895677) (← links)
• Teratogen update: azathioprine and 6-mercaptopurine. (Q34124884) (← links)
• Pharmacokinetic considerations in the treatment of inflammatory bowel disease (Q34437920) (← links)
• Azathioprine: State of the Art in Inflammatory Bowel Disease (Q34461418) (← links)
• Inflammatory bowel disease in the pediatric and adolescent patient (Q34745704) (← links)
• Azathioprine and anti-TNF alpha therapies in Crohn's disease: a review of pharmacology, clinical efficacy and safety (Q35044577) (← links)
• Azathioprine, 6-mercaptopurine in inflammatory bowel disease: pharmacology, efficacy, and safety (Q35881304) (← links)
• Novel approaches to inflammatory bowel disease (Q36181229) (← links)
• A Comparative Analysis of Drug-Induced Hepatotoxicity in Clinically Relevant Situations (Q36267296) (← links)
• Immunomodulatory therapy for ocular inflammatory disease: a basic manual and review of the literature (Q36371451) (← links)
• Thiopurine treatment in inflammatory bowel disease: clinical pharmacology and implication of pharmacogenetically guided dosing (Q36747429) (← links)
• Safety and efficacy of immunomodulators and biologics during pregnancy and lactation for the treatment of inflammatory bowel disease (Q36989959) (← links)
• Azathioprine, Mercaptopurine, and 5-Aminosalicylic Acid Affect the Growth of IBD-Associated Campylobacter Species and Other Enteric Microbes (Q37729532) (← links)
• The genetics of inflammatory bowel disease: diagnostic and therapeutic implications (Q37779753) (← links)
• Drug choices in autoimmune hepatitis: part B--Nonsteroids (Q38051706) (← links)
• Genes and beans: pharmacogenomics of renal transplant (Q38104742) (← links)
• Biopharmaceutical considerations and characterizations in development of colon targeted dosage forms for inflammatory bowel disease (Q38383015) (← links)
• Pharmacokinetic modeling of therapies for systemic lupus erythematosus. (Q38542910) (← links)
• CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4 T lymphocytes (Q39744964) (← links)
• Helicobacter pylori Infection, Reflux Esophagitis, and Atrophic Gastritis: An Unexplored Triangle (Q41727912) (← links)
• Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients. (Q42775209) (← links)
• Steady-state of azathioprine during initiation treatment of pediatric inflammatory bowel disease (Q42788628) (← links)
• Utility of Measuring 6-Methylmercaptopurine and 6-Thioguanine Nucleotide Levels in Managing Inflammatory Bowel Disease Patients Treated With 6-Mercaptopurine in a Clinical Practice Setting (Q44408690) (← links)
• Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease (Q45151580) (← links)
• Application of liposomes in treatment of rheumatoid arthritis: quo vadis (Q59101195) (← links)
• Clinical Pharmacokinetic and Pharmacodynamic Considerations in the Treatment of Ulcerative Colitis. (Q64885429) (← links)
• Sequential group trial to determine gastrointestinal site of absorption and systemic exposure of azathioprine (Q73009245) (← links)
• [Clinical tolerance to high doses intravenous azathioprinein patients with autoimmune diseases] (Q73227611) (← links)
• Topical azathioprine in the combined treatment of chronic oral graft-versus-host disease (Q73586589) (← links)
• Pharmacoeconomic analyses of azathioprine, methotrexate and prospective pharmacogenetic testing for the management of inflammatory bowel disease (Q80086489) (← links)
• Mycophenolate mofetil, azathioprine and tacrolimus: mechanisms in rheumatology (Q89702114) (← links)
• The potential application of human PIG-A assay on azathioprine-treated inflammatory bowel disease patients (Q91339259) (← links)
• Immunosuppressive drugs and the gastrointestinal tract in renal transplant patients (Q93350375) (← links)